The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients.

Waleed AlbakerMona Al SheikhAishah AlbakrDania AlkhafajiEman Al BesherMohammad T Al-Hariri

Published in: International journal of general medicine (2021)

Daily s/c Liraglutide of 3.0 mg is effective in producing significant body weight reduction in obese non-diabetic Saudi patients with tolerable minimal side effects and may provide health benefits in terms of reduced risk of obesity and its related outcomes.

Keyphrases

body weight
weight loss
type diabetes
metabolic syndrome
bariatric surgery
adipose tissue
insulin resistance
wound healing
glycemic control
public health
healthcare
weight gain
saudi arabia
physical activity
obese patients
mental health
health promotion